SHENGSHI MEDICAL TRAVEL
Explore Lecheng's special-access medicines
Search medicine names and published indications from Lecheng’s public special-access catalogue, with links to each source.
Search medicine names and clinical topics. These are public catalogue records, including different brands or formulations; the count is not a count of unique active ingredients. This is a reference library, not an online pharmacy.
Source: Boao Lecheng International Medicines & Devices, formerly the Central Pharmacy. Its special-access medicine category contained 208 records at review; 3 lacked an extractable indication. Devices and international innovation listings are separate and are not added to this medicine count. A listing does not confirm current stock, approval for your condition or eligibility to take medicine abroad.
Open source catalogue ↗205 matching records
Rare and inherited conditions
Vimizim(elosulfase alfa)
依洛硫酸酯酶 α
Published indication · Chinese source
适用于治疗所有年龄段的 IVA 型黏多糖贮积症患者(Morquio A 综合征,MPS IVA)
First institution listed: 上海交通大学医学院附属瑞金医院海南医院(海南博鳌研究型医院)
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Blood cancers
Dasatinib Tablets(PHYRAGO)
达沙替尼片
Published indication · Chinese source
新诊断的费城染色体阳性(Ph+)慢性期慢性髓性白血病(CML)成人患者。对既往治疗(包括伊马替尼)耐药或不耐受的慢性期、加速期、髓系或淋系急变期Ph+CML成人患者。对既往治疗耐药或不耐受的费城染色体阳性急性淋巴细胞白血病(Ph+ALL)成人患者。1岁及以上Ph+慢性期CML儿科患者。1岁及以上新诊断的Ph+ALL儿科患者(联合化疗)。
First institution listed: 博鳌超级医院
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Kidney conditions · Immune and inflammatory conditions
Pegcetacoplan(Aspaveli)
安帕威利
Published indication · Chinese source
ASPAVELI适用于作为单药治疗患有溶血性贫血的阵发性夜间血红蛋白尿(PNH)成人患者。 ASPAVELI适用于联合肾素-血管紧张素系统(RAS)抑制剂治疗C3肾小球病(C3G)或原发性免疫复合物性膜增生性肾小球肾炎(IC-MPGN)成人和12-17岁青少年患者,除非患者不耐受或禁用RAS抑制剂治疗。
First institution listed: 上海交通大学医学院附属瑞金医院海南医院
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Neurology
Lecanemab-irmb(LEQEMBIIQLIK)
仑卡奈单抗
Published indication · Chinese source
仑卡奈单抗是一种靶向β淀粉样蛋白的抗体,适用于治疗阿尔茨海默病。应在处于轻度认知障碍或轻度痴呆疾病阶段的患者中开始仑卡奈单抗治疗,该人群为临床试验中开始治疗的人群。
First institution listed: 上海交通大学医学院附属瑞金医院海南医院
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Digestive and liver conditions
Defitelio(defibrotide)
去纤苷
Published indication · Chinese source
去纤苷适用于治疗造血干细胞移植(HSCT)后引起的肝小静脉闭塞病(VOD),也称为肝窦阻塞综合征(sOs)。适用于成人、青少年、儿童及一个月以上的儿童。
First institution listed: 上海交通大学医学院附属瑞金医院海南医院
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Neurology · Cardiovascular conditions
Amvuttra(vutrisiran)
夫曲司兰
Published indication · Chinese source
治疗成人遗传性转甲状腺素蛋白淀粉样变性多发性神经病(hATTR-PN);治疗成人野生型或遗传性转甲状腺素蛋白淀粉样变性心肌病(ATTR-CM),以降低心血管死亡率、心血管住院率和紧急心力衰竭就诊率。
First institution listed: 上海交通大学医学院附属瑞金医院海南医院
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Kidney conditions
Tolvaptan (JINARC)
托伐普坦
Published indication · Chinese source
常染色体显性多囊肾病(ADPKD)伴慢性肾病(CKD)患者,出现快速进展迹象时,使用Jinarc延缓囊肿和肾功能不全的进展。
First institution listed: 上海交通大学医学院附属瑞金医院海南医院
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Kidney conditions
Tolvaptan (JINARC)
托伐普坦
Published indication · Chinese source
常染色体显性多囊肾病(ADPKD)伴慢性肾病(CKD)患者,出现快速进展迹象时,使用Jinarc延缓囊肿和肾功能不全的进展。
First institution listed: 上海交通大学医学院附属瑞金医院海南医院
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Kidney conditions
Tolvaptan (JINARC)
托伐普坦
Published indication · Chinese source
常染色体显性多囊肾病(ADPKD)伴慢性肾病(CKD)患者,出现快速进展迹象时,使用Jinarc延缓囊肿和肾功能不全的进展。
First institution listed: 上海交通大学医学院附属瑞金医院海南医院
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Specialist review
Glycopyrronium bromide ( Axhidrox)
格隆溴铵
Published indication · Chinese source
用于成人严重的原发性腋窝多汗症的局部治疗
First institution listed: 树兰(博鳌)医院
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Specialist review
carbachol and brimonidine tartrate ophthalmic solution (YUVEZZI)
卡巴胆碱与酒石酸溴莫尼定滴眼液
Published indication · Chinese source
用于治疗成人老视
First institution listed: 博鳌超级医院
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Specialist review
Cholbam (cholic acid capsule)
胆酸胶囊
Published indication · Chinese source
适用于治疗单酶缺陷(SEDs)引起的胆汁酸合成障碍。
First institution listed: 博鳌未来医院
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Specialist review
RYANODEX(dantrolene sodium)
注射用丹曲林钠混悬剂
Published indication · Chinese source
1.结合适当的支持措施治疗恶性高热; 2.预防高危患者的恶性高热。
First institution listed: 上海交通大学医学院附属瑞金医院海南医院(海南博整研究型医院)
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Cancer · Skin conditions
Ingaron
重组人干扰素γ
Published indication · Chinese source
治疗播散性皮肤黑色素瘤、局部晚期及播散性乳腺癌,(作为免疫调节剂,可单独使用,也可与化疗联合使用)。
First institution listed: 博鳌超级医院
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Specialist review
Alesion Eyelid Cream
盐酸依匹斯汀乳膏
Published indication · Chinese source
用于12岁以上人群过敏性结膜炎。
First institution listed: 博鳌超级医院
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Cancer · Immune and inflammatory conditions
Refnot
重组肿瘤坏死因子-胸腺素α1
Published indication · Chinese source
联合化疗用于乳腺癌治疗;作为免疫调节剂用于晚期黑色素瘤治疗。
First institution listed: 博鳌超级医院
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Cancer
Sevabertinib(HYRNUO)
塞伐艾替尼
Published indication · Chinese source
国外获批适应症适用于治疗经 FDA 批准的检测方法确认携带 HER2(ERBB2)酪氨酸激酶结构域(TKD)激活突变且既往接受过一种全身性治疗的局部晚期或转移性非鳞状非小细胞肺癌(NSCLC)成人患者。
First institution listed: 上海交通大学医学院附属瑞金医院海南医院
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Specialist review
Actair(Mixture of American (D. farinae) and European (D. pteronyssinus) House dust mite allergen extracts)
尘螨变应原舌下片
Published indication · Chinese source
治疗确诊为尘螨过敏的成人、青少年和5岁及以上儿童的过敏性鼻炎伴或不伴结膜炎。
First institution listed: 上海交通大学医学院附属瑞金医院海南医院
Exact eligibility and current availability require hospital confirmation. An interpreter can help review the Chinese source with you.
Read the source ↗Before considering special access
Ask the hospital to verify the diagnosis, full indication, local access pathway, expected benefit, risks, alternatives, availability and itemised price. Do not select a medicine from a symptom alone or stop current care. Published first-use institutions are source information, not a claim of partnership with Shengshi.
Discuss a specialist reviewYOUR NEXT STEP
Start with a conversation.
Tell us your preferred language, travel dates and the support you need. We will explain the next steps before you book.
